HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Mark E Bardgett Selected Research
Mark E Bardgett Research Topics
Disease
3
Schizophrenia (Dementia Praecox)
11/2010 - 07/2008
2
Mental Disorders (Mental Disorder)
01/2019 - 03/2015
2
Autistic Disorder (Autism)
03/2015 - 06/2013
2
Alzheimer Disease (Alzheimer's Disease)
01/2011 - 07/2008
2
Memory Disorders (Memory Loss)
07/2008 - 04/2003
1
Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
11/2020
1
Conduct Disorder (Conduct Disorders)
11/2020
1
Weight Gain
06/2013
1
Neuronal Ceroid-Lipofuscinoses (Neuronal Ceroid Lipofuscinosis)
05/2013
1
Synucleinopathies
05/2013
1
Kufor-Rakeb syndrome
05/2013
1
Ataxia (Dyssynergia)
11/2010
1
Hypersensitivity (Allergy)
03/2005
1
Shock
04/2003
1
Cognitive Dysfunction
04/2003
Drug/Important Bio-Agent (IBA)
4
Antipsychotic Agents (Antipsychotics)
IBA
11/2020 - 06/2013
4
Dizocilpine Maleate (Dizocilpine)
IBA
11/2010 - 04/2003
3
Risperidone (Risperdal Consta)
FDA Link
Generic
11/2020 - 06/2013
3
N-Methyl-D-Aspartate Receptors (NMDA Receptors)
IBA
09/2009 - 04/2003
2
ciproxifan
IBA
01/2011 - 11/2010
2
N-Methylaspartate (NMDA)
IBA
07/2008 - 03/2005
1
Synucleins
IBA
05/2013
1
Lipofuscin
IBA
05/2013
1
P-type ATPases
IBA
05/2013
1
Histamine H3 Receptors (Histamine H3 Receptor)
IBA
01/2011
1
Phencyclidine (Angel Dust)
IBA
07/2008
1
Adrenergic Agonists (Adrenergic Receptor Agonist)
IBA
07/2008
1
Clonidine (ST 155)
FDA Link
Generic
07/2008
1
Glutamic Acid (Glutamate)
FDA Link
07/2008
1
Glutamate Receptors (Glutamate Receptor)
IBA
03/2005